August 1, 2018
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Reviews in this issue: Viral Suppression and Cancer Incidence among HIV-Infected U.S. Veterans; Can MRSA Nares Screening Results Be Used to Rule Out MRSA Pneumonia?; Fidaxomicin Provides Effective Prophylaxis Against CDI in Hematopoietic Stem Cell Transplant Recipients
The House Energy and Commerce Committee Health Subcommittee held a hearing last week on implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) and the Merit-Based Incentive Payment System (MIPS).Read More
The HIV community, led by the Act Now END AIDS Coalition, is developing a national blueprint to end AIDS as an epidemic.Read More
The House Energy and Commerce Committee has approved the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization bill which includes a new provision spearheaded by IDSA to support the development of our public health workforce, including ID physicians.Read More
Don’t miss The International Foundation for Alternative Research in AIDS (IFARA’s) Interview with HIVMA Clinical Fellows (2017-2018) Yury Parra, MD and Vanessa Rojas, MD at AIDS 2018. They talk about their work in HIV that resulted in being granted the award, funded by the IDSA Foundation, and what the fellowship means to them.Read More